BioCryst Pharmaceuticals Inc

NAS:BCRXHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$8.07+3.59%At closeAt close · Tue 20 Oct · ≈ AED 29.64 · Market cap $2.06B · Next earnings Mon 2 Nov · Extended $8.07 +0.00%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	90.6%	95.4%	97.6%	98.6%	97.2%	97.8%	—	—
Operating margin	−981.1%	−113.1%	−54.8%	−31.3%	−0.6%	39.0%	39.0%	+0.0 pts
Net margin	−1,026.4%	−117.1%	−91.2%	−68.4%	−19.7%	30.2%	30.2%	+0.0 pts
EBITDA margin	−940.7%	−77.5%	−53.1%	−35.1%	2.8%	39.7%	—	—
Return on equity	949.1%	172.0%	83.9%	49.7%	18.7%	−221.4%	−221.4%	+0.0 pts
Return on assets	−54.6%	−31.3%	−44.9%	−43.8%	−18.1%	51.3%	51.3%	+0.0 pts
Return on capital employed	−76.3%	−36.7%	−33.4%	−28.3%	−0.8%	107.2%	—	—
Debt / equity	−14.5×	−5.5×	−2.5×	−1.8×	−1.8×	−3.7×	−3.7×	+0.0%
Debt / assets	83.5%	100.9%	134.8%	159.6%	171.6%	85.4%	—	—
Interest coverage	−12.1×	−3.0×	−1.5×	−1.0×	−0.0×	4.3×	—	—
Current ratio	3.1×	5.5×	4.9×	3.3×	2.6×	2.1×	2.1×	+0.0%
Quick ratio	3.0×	5.3×	4.6×	3.1×	2.6×	2.0×	—	—
Cash ratio	2.6×	4.9×	2.9×	0.7×	0.7×	0.5×	0.5×	+0.0%
Asset turnover	0.1×	0.3×	0.5×	0.6×	0.9×	1.7×	—	—
Inventory turnover	0.2×	0.5×	0.2×	0.2×	1.5×	3.5×	—	—
Receivables turnover	2.1×	5.3×	5.4×	5.8×	5.7×	8.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.